Wednesday, July 8, 2026

Intelligence · Clinical Development

Pipeline search results

Programs matching “methylprednisolone” across our ClinicalTrials.gov index — phase, modality, sponsor, and trial IDs.

Matching programs 9
Total indexed 20,548
Sponsors 1,769

Quick answer

Showing 9 pipeline programs matching "methylprednisolone" from NovaPharmaNews Clinical Development Intelligence — phase, modality, sponsor, and ClinicalTrials.gov trial IDs.

Refine search

9 results for “methylprednisolone” Back to intelligence hub

Search results

  1. Intravenous Methylprednisolone

    Cardiff Oncology

    Myelitis, Transverse

    phase 3 small molecule terminated

    1 trial
  2. METHYLPREDNISOLONE , ACETYLCYSTEINE

    The George Institute

    Acute Alcoholic hepatitis

    phase 3 small molecule active

    1 trial
  3. Methylprednisolone pulse

    The First People's Hospital of Lianyungang

    Glomerulonephritis, IGA

    phase 3 small molecule terminated

    1 trial
  4. Methylprednisolone sodium succinate

    The First People's Hospital of Lianyungang

    Acute Ischemic Stroke

    phase 3 small molecule active

    1 trial
  5. The methylprednisolone sodium succinate

    The First People's Hospital of Lianyungang

    Acute Ischemic Stroke

    phase 3 small molecule active

    1 trial
  6. methylprednisolone

    Ultragenyx UK Limited

    Spinal Cord Injury

    phase 3 small molecule completed

    1 trial
  7. methylprednisolone

    Teva Pharma GmbH

    Multiple Sclerosis (MS)

    phase 2 small molecule terminated

    1 trial
  8. Methylprednisolone (Injectable Form)

    Universal Integrated

    Unruptured Intracranial Aneurysms

    approved small molecule active

    1 trial
  9. Methylprednisolone and Mycophenolate mofetil

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Autoimmune Hepatitis

    approved small molecule active

    1 trial

Frequently asked questions

What is the Clinical Development Intelligence Platform?

It is NovaPharmaNews pipeline intelligence hub covering 20,548 clinical development programs — not just a directory. It includes phase distribution dashboards, therapeutic area overviews, NDA/BLA watchlists, upcoming readouts, company pipeline rankings, competitive landscape maps, and personalized watchlists.

How does this compare to Evaluate Pharma or Citeline?

Like Evaluate Pharma and Citeline Trialtrove, we index ClinicalTrials.gov programs by sponsor, phase, and indication. Our platform adds cross-links to NovaPharmaNews company profiles, drug INN pages, patents, and congress readout calendars — improving crawl depth and reducing orphan program pages.

Where does pipeline data come from?

Program records derive from ClinicalTrials.gov and link to sponsor company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment decisions. See our data sources page for attribution.

Can I follow a company or program for updates?

Yes — use the watchlist forms on this page to follow sponsors, individual programs, disease clusters, or therapeutic areas. Alerts use the same subscription infrastructure as our events intelligence hub.